Revolutionising Non-Melanoma Skin Cancer Treatment: Initiating Rhenium-SCT Therapy - European Medical Journal

Revolutionising Non-Melanoma Skin Cancer Treatment: Initiating Rhenium-SCT Therapy

Dermatology

The EMJ Podcast | Bonus Episode

This podcast has been sponsored by OncoBeta, a medical device company specialising in innovative epidermal radioisotope therapies. 

Spotify | Apple | Amazon Music | Download MP3 (18:10 mins)

 

Don’t miss the final episode of our three-part series exploring how Rhenium skin cancer therapy (SCT) is transforming non-melanoma skin cancer treatment! Join Carmen García-Donoso and Diana Vega Pérez as they discuss their clinical experience of the novel painless, non-invasive, single-session therapy.

 

This episode explores:

  • What makes patients viable for Rhenium-SCT;
  • Their real-world experiences using Rhenium-SCT in practice; and
  • Potential challenges and how they could be addressed.

Speakers

Carmen Garcia-Donoso1

 

Diana Vega Pérez2

 

1. Dermatologist, Hospital 12 de Octubre, Madrid, Spain
2. Nuclear Medicine, Hospital 12 de Octubre, Madrid, Spain  

 

Catch up on the other episodes below:

Part 1, ‘Treating Non-melanoma Skin Cancer with the Non-invasive, Single Session Approach Rhenium-SCT’.
Part 2, ‘Revolutionising Non-Melanoma Skin Cancer Treatment with Rhenium SCT: A Non-Invasive Single-Session Approach

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.